Johnson Matthey, a provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, and Domainex Ltd., a small-molecule drug discovery company, have entered a collaboration to provide integrated small molecule discovery and development services to pharma/biopharma companies and academia across the UK. The companies aim to provide effective, simplified, rapid and reduced risk target-to-lead identification, optimization, safety/toxicology, preclinical and cl...